Condition 1: Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset. Condition 2: Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures. Condition 3: Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures. Condition 4: Generalized idiopathic epilepsy and epileptic syndromes. Condition 5: Other generalized epilepsy and epil
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Individuals were eligible if they had been diagnosed of epilepsy by a neurologist, diagnosed with epilepsy for at least 6 months; were receiving antiepileptic drugs (AEDs); were 18 years old and elder ; were able to understand and speak Persian ; had a telephone (or access to one).Residents in Isfahan and its surrounding. Exclusion criteria: Unwilling to participate in Clinical Trial Hospitalized for any reason during the training sessions Non participate in any of education session (in education and education plus telephone follow up groups) - No answer to 2 or more phone contacts(in education plus telephone follow up group)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Epilepsy self-management. Timepoint: At baseline - 4months after. Method of measurement: Epilepsy Self-Management Scale(ESMS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Age. Timepoint: At baseline. Method of measurement: Demographic information.;Gender. Timepoint: At baseline. Method of measurement: Demographic information.;Education level. Timepoint: At baseline. Method of measurement: Demographic information.;Marital status. Timepoint: At baseline. Method of measurement: Demographic information.;Occupation. Timepoint: At baseline. Method of measurement: Demographic information.;Economic status. Timepoint: At baseline. Method of measurement: Demographic information.;Insurance. Timepoint: At baseline. Method of measurement: Demographic information.;Duration of disease. Timepoint: At baseline. Method of measurement: Demographic information.;Type of seizure. Timepoint: At baseline. Method of measurement: Demographic information.;Number of Antiepileptic Drugs. Timepoint: At baseline. Method of measurement: Demographic information.;Frequency of seizure. Timepoint: At baseline. Method of measurement: Demographic information.;Other disease. Timepoint: At baseline. Method of measurement: Demographic information. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran university of medical sience